August 30, 2026
SOHO Insider Hem/Onc Library Multiple Myeloma

Multiple Myeloma News

Focus on CELMoDs EHA 2026 Meetings / Conferences Multiple Myeloma Roundtable Discussions Video Interviews

Where do CELMoDs, including mezigdomide and iberdomide, fit in the myeloma treatment landscape?

China flag
Multiple Myeloma News

NMPA grants approval to felzartamab in multiple myeloma

FDA
Multiple Myeloma News

FDA grants accelerated approval to iberdomide combo in multiple myeloma

FDA laptop
Multiple Myeloma News

FDA approves subcutaneous isatuximab-irfc for multiple myeloma

Focus on CELMoDs EHA 2026 Meetings / Conferences Multiple Myeloma Roundtable Discussions Video Interviews

How to sequence mezigdomide-based therapy in myeloma?

Insider_YT_Ponce_400x400
EHA 2026 Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Meetings / Conferences Multiple Myeloma Video Interviews

Doris Ponce, MD, discusses bone health findings with axatilimab in chronic GVHD

Focus on CELMoDs EHA 2026 Meetings / Conferences Multiple Myeloma Roundtable Discussions Video Interviews

How can trispecifics be integrated with CELMoDs in myeloma treatment?

FDA laptop
Multiple Myeloma News

FDA accepts NDA for mezigdomide combo in relapsed or refractory myeloma

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope
Multiple Myeloma News

Clinical use assay launched for MRD detection in myeloma

Doctor at laptop
Multiple Myeloma News

Phase 3 trial finds no survival benefit for indefinite maintenance in multiple myeloma